Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1979 Apr;25:467–472.

Diagnosis and Management of Involutional Osteoporosis

P Michael Hodsman
PMCID: PMC2383039  PMID: 21297728

Abstract

Of postmenopausal women, 20-30% will experience symptomatic involutional osteoporosis. Though the cause is still poorly defined, recent information gives the family physician several routes to treat effectively most patients who become symptomatic. Two other responsibilities exist, however: defining occult causes for the porotic process which may be of greater importance than the osteoporosis itself, and attempting to treat patients at risk for future osteoporosis prophylactically. The latter is a task where we have very effective modes of therapy, but we are only just beginning to develop means of defining that populace destined to suffer from future osteoporosis.

Full text

PDF
467

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken J. M., Hart D. M., Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J. 1973 Sep 8;3(5879):515–518. doi: 10.1136/bmj.3.5879.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Albanese A. A. Calcium nutrition in the elderly: maintaining bone health to minimize fracture risk. Postgrad Med. 1978 Mar;63(3):167–172. doi: 10.1080/00325481.1978.11714787. [DOI] [PubMed] [Google Scholar]
  3. Aloia J. F., Cohn S. H., Ostuni J. A., Cane R., Ellis K. Prevention of involutional bone loss by exercise. Ann Intern Med. 1978 Sep;89(3):356–358. doi: 10.7326/0003-4819-89-3-356. [DOI] [PubMed] [Google Scholar]
  4. Aloia J. F., Zanzi I., Ellis K., Jowsey J., Roginsky M., Wallach S., Cohn S. H. Effects of growth hormone in osteoporosis. J Clin Endocrinol Metab. 1976 Nov;43(5):992–999. doi: 10.1210/jcem-43-5-992. [DOI] [PubMed] [Google Scholar]
  5. Antunes C. M., Strolley P. D., Rosenshein N. B., Davies J. L., Tonascia J. A., Brown C., Burnett L., Rutledge A., Pokempner M., Garcia R. Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med. 1979 Jan 4;300(1):9–13. doi: 10.1056/NEJM197901043000103. [DOI] [PubMed] [Google Scholar]
  6. Avioli L. V. Senile and postmenopausal osteoporosis. Adv Intern Med. 1976;21:391–415. [PubMed] [Google Scholar]
  7. Bullamore J. R., Wilkinson R., Gallagher J. C., Nordin B. E., Marshall D. H. Effect of age on calcium absorption. Lancet. 1970 Sep 12;2(7672):535–537. doi: 10.1016/s0140-6736(70)91344-9. [DOI] [PubMed] [Google Scholar]
  8. Chalmers J., Ho K. C. Geographical variations in senile osteoporosis. The association with physical activity. J Bone Joint Surg Br. 1970 Nov;52(4):667–675. [PubMed] [Google Scholar]
  9. Daniell H. W. Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch Intern Med. 1976 Mar;136(3):298–304. doi: 10.1001/archinte.136.3.298. [DOI] [PubMed] [Google Scholar]
  10. Davies M., Mawer E. B., Adams P. H. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis. J Clin Endocrinol Metab. 1977 Aug;45(2):199–208. doi: 10.1210/jcem-45-2-199. [DOI] [PubMed] [Google Scholar]
  11. Detre T., Hayashi T. T., Archer D. F. Management of the Menopause. Ann Intern Med. 1978 Mar;88(3):373–378. doi: 10.7326/0003-4819-88-3-373. [DOI] [PubMed] [Google Scholar]
  12. Faccini J. M., Exton-Smith A. N., Boyde A. Disorders of bone and fracture of the femoral neck. Evaluation of computer image analysis in diagnosis. Lancet. 1976 May 22;1(7969):1089–1092. doi: 10.1016/s0140-6736(76)90060-x. [DOI] [PubMed] [Google Scholar]
  13. Gallagher J. C., Aaron J., Horsman A., Marshall D. H., Wilkinson R., Nordin B. E. The crush fracture syndrome in postmenopausal women. Clin Endocrinol Metab. 1973 Jul;2(2):293–315. doi: 10.1016/s0300-595x(73)80045-3. [DOI] [PubMed] [Google Scholar]
  14. Goldsmith R. S. Treatment of osteoporosis with phosphate. Semin Drug Treat. 1972 Summer;2(1):35–37. [PubMed] [Google Scholar]
  15. Gordan G. S. Drug treatment of the osteoporoses. Annu Rev Pharmacol Toxicol. 1978;18:253–268. doi: 10.1146/annurev.pa.18.040178.001345. [DOI] [PubMed] [Google Scholar]
  16. Gordan G. S., Picchi J., Roof B. S. Antifracture efficacy of long-term estrogens for osteoporosis. Trans Assoc Am Physicians. 1973;86:326–332. [PubMed] [Google Scholar]
  17. Gordan G. S. Recent progress in calcium metabolism: clinical application. Calif Med. 1971 May;114(5):28–43. [PMC free article] [PubMed] [Google Scholar]
  18. HARRISON M., FRASER R., MULLAN B. Calcium metabolism in osteoporosis. Acute and long-term responses to increased calcium intake. Lancet. 1961 May 13;1(7185):1015–1019. doi: 10.1016/s0140-6736(61)91828-1. [DOI] [PubMed] [Google Scholar]
  19. Heaney R. P. A unified concept of osteoporosis. Am J Med. 1965 Dec;39(6):877–880. doi: 10.1016/0002-9343(65)90109-9. [DOI] [PubMed] [Google Scholar]
  20. Heaney R. P., Saville P. D. Etidronate disodium in postmenopausal osteoporosis. Clin Pharmacol Ther. 1976 Nov;20(5):593–604. doi: 10.1002/cpt1976205593. [DOI] [PubMed] [Google Scholar]
  21. Heaney R. P., Saville P. D., Recker R. R. Calcium absorption as a function of calcium intake. J Lab Clin Med. 1975 Jun;85(6):881–890. [PubMed] [Google Scholar]
  22. Hertz R. Evaluation of current information concerning the relationship between hormonal usage and cancer. Clin Obstet Gynecol. 1977 Mar;20(1):165–175. doi: 10.1097/00003081-197703000-00020. [DOI] [PubMed] [Google Scholar]
  23. JASANI C., NORDIN B. E., SMITH D. A., SWANSON I. SPINAL OSTEOPOROSIS AND THE MENOPAUSE. Proc R Soc Med. 1965 Jun;58:441–444. doi: 10.1177/003591576505800622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jowsey J. Osteoporosis: dealing with a crippling bone disease of the elderly. Geriatrics. 1977 Jul;32(7):41–50. [PubMed] [Google Scholar]
  25. Jowsey J., Raisz L. G. Experimental osteoporosis and parathyroid activity. Endocrinology. 1968 Feb;82(2):384–396. doi: 10.1210/endo-82-2-384. [DOI] [PubMed] [Google Scholar]
  26. Jowsey J., Reiss E., Canterbury J. M. Long-term effects of high phosphate intake on parathyroid hormone levels and bone metabolism. Acta Orthop Scand. 1974;45(6):801–808. doi: 10.3109/17453677408989691. [DOI] [PubMed] [Google Scholar]
  27. Jowsey J., Riggs B. L., Kelly P. J., Hoffmann D. L. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med. 1972 Jul;53(1):43–49. doi: 10.1016/0002-9343(72)90114-3. [DOI] [PubMed] [Google Scholar]
  28. Lindsay R., Hart D. M., Aitken J. M., MacDonald E. B., Anderson J. B., Clarke A. C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976 May 15;1(7968):1038–1041. doi: 10.1016/s0140-6736(76)92217-0. [DOI] [PubMed] [Google Scholar]
  29. Lindsay R., Hart D. M., Purdie D., Ferguson M. M., Clark A. S., Kraszewski A. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med. 1978 Feb;54(2):193–195. doi: 10.1042/cs0540193. [DOI] [PubMed] [Google Scholar]
  30. Lund B., Hjorth L., Kjaer I., Reimann I., Friis T., Andersen R. B., Sorensen O. H. Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol. Lancet. 1975 Dec 13;2(7946):1168–1171. doi: 10.1016/s0140-6736(75)92656-2. [DOI] [PubMed] [Google Scholar]
  31. Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 1976 Jun 3;294(23):1262–1267. doi: 10.1056/NEJM197606032942304. [DOI] [PubMed] [Google Scholar]
  32. Meema S., Bunker M. L., Meema H. E. Preventive effect of estrogen on postmenopausal bone loss. Arch Intern Med. 1975 Nov;135(11):1436–1440. [PubMed] [Google Scholar]
  33. Meema S., Meema H. E. Menopausal bone loss and estrogen replacement. Isr J Med Sci. 1976 Jul;12(7):601–606. [PubMed] [Google Scholar]
  34. NORDIN B. E. The pathogenesis of osteoporosis. Lancet. 1961 May 13;1(7185):1011–1015. doi: 10.1016/s0140-6736(61)91827-x. [DOI] [PubMed] [Google Scholar]
  35. Newcomer A. D., Hodgson S. F., McGill D. B., Thomas P. J. Lactase deficiency: prevalence in osteoporosis. Ann Intern Med. 1978 Aug;89(2):218–220. doi: 10.7326/0003-4819-89-2-218. [DOI] [PubMed] [Google Scholar]
  36. Nilsson B. E., Westlin N. E. Bone density in athletes. Clin Orthop Relat Res. 1971;77:179–182. [PubMed] [Google Scholar]
  37. Recker R. R., Saville P. D., Heaney R. P. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med. 1977 Dec;87(6):649–655. doi: 10.7326/0003-4819-87-6-649. [DOI] [PubMed] [Google Scholar]
  38. Riggs B. L., Jowsey J., Goldsmith R. S., Kelly P. J., Hoffman D. L., Arnaud C. D. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. J Clin Invest. 1972 Jul;51(7):1659–1663. doi: 10.1172/JCI106967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Riggs B. L., Jowsey J., Kelly P. J., Hoffman D. L., Arnaud C. D. Effects of oral therapy with calcium and vitamin D in primary osteoporosis. J Clin Endocrinol Metab. 1976 Jun;42(6):1139–1144. doi: 10.1210/jcem-42-6-1139. [DOI] [PubMed] [Google Scholar]
  40. Riggs B. L., Kelly P. J., Kinney W. R., Scholz D. A., Bianco A. J., Jr Calcium deficiency and osteoporosis. Observations in one hundred and sixty-six patients and critical review of the literature. J Bone Joint Surg Am. 1967 Jul;49(5):915–924. [PubMed] [Google Scholar]
  41. Singh M., Riggs B. L., Beabout J. W., Jowsey J. Femoral trabecular-pattern index for evaluation of spinal osteoporosis. Ann Intern Med. 1972 Jul;77(1):63–67. doi: 10.7326/0003-4819-77-1-63. [DOI] [PubMed] [Google Scholar]
  42. Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975 Dec 4;293(23):1164–1167. doi: 10.1056/NEJM197512042932302. [DOI] [PubMed] [Google Scholar]
  43. Smith E. L., Reddan W. Proceedings: Physical activity--a modality for bone accretion in the aged. AJR Am J Roentgenol. 1976 Jun;126(6):1297–1297. doi: 10.2214/ajr.126.6.1297. [DOI] [PubMed] [Google Scholar]
  44. Smith R. W., Jr Dietary and hormonal factors in bone loss. Fed Proc. 1967 Nov-Dec;26(6):1737–1746. [PubMed] [Google Scholar]
  45. Teitelbaum S. L., Rosenberg E. M., Richardson C. A., Avioli L. V. Histological studies of bone from normocalcemic post-menopausal osteoporotic patients with increased circulating parathyroid hormone. J Clin Endocrinol Metab. 1976 Mar;42(3):537–543. doi: 10.1210/jcem-42-3-537. [DOI] [PubMed] [Google Scholar]
  46. Thomson D. L., Frame B. Involutional osteopenia: current concepts. Ann Intern Med. 1976 Dec;85(6):789–803. doi: 10.7326/0003-4819-85-6-789. [DOI] [PubMed] [Google Scholar]
  47. Vaughan C. C. Rehabilitation in postmenopausal osteoporosis. Isr J Med Sci. 1976 Jul;12(7):652–659. [PubMed] [Google Scholar]
  48. Walton J., Dominquez M., Bartter F. C. Effects of calcium infusions in patients with postmenopausal osteoporosis. Metabolism. 1975 Jul;24(7):849–854. doi: 10.1016/0026-0495(75)90131-6. [DOI] [PubMed] [Google Scholar]
  49. Weiss N. S., Szekely D. R., Austin D. F. Increasing incidence of endometrial cancer in the United States. N Engl J Med. 1976 Jun 3;294(23):1259–1262. doi: 10.1056/NEJM197606032942303. [DOI] [PubMed] [Google Scholar]
  50. Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES